Propanc Biopharma (NASDAQ: PPCB) is owned by 0.00% institutional shareholders, 0.00% Propanc Biopharma insiders, and 100.00% retail investors. Janstr is the largest individual Propanc Biopharma shareholder, owning 26.00 shares representing 0.00% of the company. Janstr's Propanc Biopharma shares are currently valued at $31.72.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.